Mpox Vaccine Now Available at the Thai Red Cross: Price and Who Should Get It
After Thailand's Department of Disease Control announced the country's first case of Mpox (Clade 1) in a traveler returning from Africa, the Thai Red Cross…
อ่านภาษาไทย
Contents
After Thailand's Department of Disease Control announced the country's first case of Mpox (monkeypox), Clade 1 strain, in a person who had traveled from Africa, interest in a vaccine to prevent the disease surged. In response, the Thai Red Cross Society now offers an Mpox vaccine for people aged 18 and over, starting at 2,200 baht. Those interested can choose from two methods of administration: subcutaneous injection and intradermal injection, which can prevent the disease by 80-85 percent.
Who should get the Mpox vaccine
Dr. Apichat Wachiraphan, Deputy Director-General of the Department of Disease Control, recommends the Mpox vaccine for two groups:
- Medical service providers, such as healthcare personnel who must work in outbreak areas.
- People who have already been exposed, such as those who develop lesions after sex. They can still receive the vaccine within 4 days; the immunity that develops may not provide 100 percent protection against infection, but receiving it within days 5-14 can still protect against severe illness. This requires two doses, given 28 days apart.
The Queen Saovabha Memorial Institute of the Thai Red Cross Society offers vaccination through two methods:
- Subcutaneous injection (0.5 ml), 8,500 baht per dose.
- Intradermal injection (0.1 ml), 2,200 baht per dose, provided that a group of 4 people come together.
Both methods require two injections, given 28 days apart. Services are available at the Rajudhis Building, Queen Saovabha Memorial Institute, Thai Red Cross Society.
Mpox vaccination days and hours
Monday - Friday
- 08:30-12:00 (queue tickets close at 11:30)
- 13:00-16:30 (queue tickets close at 16:00)
Saturday and public holidays
- 08:30-12:00 (queue tickets close at 11:30)
Sunday
- Closed
The Thai Red Cross Society notes that although there is no vaccine developed specifically against Mpox, this vaccine is 80-85 percent effective at prevention. It is recommended for people at high risk, such as those in close contact with someone who is infected, healthcare personnel, people living with HIV, and other at-risk groups.
Read more about Mpox: lovefoundation.or.th/mpox
Verified references
Links and relevance to the article’s main topic were reviewed on 13 August 2026. Each source supports only the scope stated in the original document and does not replace personalised medical, legal, or service advice.
- CDC: Mpox Vaccine Considerations Accessed 13 August 2026
- WHO: Mpox fact sheet Accessed 13 August 2026
- CDC: About Mpox Accessed 13 August 2026


